Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-06-15
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of carboplatin, gemcitabine, and exisulind
in treating patients who have advanced non-small cell lung cancer.